Zota Health Care LImited

Zota Health Care Limited reported strong Q1 FY27 results, with revenue from operations growing 67.6% YoY to INR 17,360 lakhs, driven by expansion of the Davaindia Network and increased consumer engagement. The company added 264 new stores, bringing total store count to 2,825, with 60 lakh customer footfalls during the quarter. Gross profit reached INR 10,756 lakhs, with gross margin improving to 61.96%. Management emphasized disciplined growth, moderating store expansion in Q2 FY27 to focus on productivity and operational efficiency. The company also highlighted investments in subsidiaries like Davaindia Health Mart, KMHP Ventures, and Curexis Ventures to build a diversified healthcare ecosystem. Marketing expenses rose due to brand ambassadorships, including Mahendra Singh Dhoni, but management noted these were necessary for brand awareness. Store-level EBITDA margins for mature stores (over two years old) were 12-15%, with expectations of improvement as newer stores mature. The company expects cash breakeven by Q1 FY28, with EBITDA positivity anticipated from Q2 FY27 onwards. Management also addressed concerns about store economics, noting that newer stores are maturing faster due to improved brand recognition and generic medicine adoption.

The document emphasizes strong revenue growth, improved margins, and strategic investments, with management expressing confidence in future profitability and market expansion.